Status:
COMPLETED
Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Postural Orthostatic Tachycardia Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In this pilot study, the investigator will test the usefulness of gabapentin in treating some of the symptoms associated with POTS. Gabapentin is FDA-approved to treat epilepsy and nerve pain and work...
Detailed Description
Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system. The autonomic nervous system regulates major bodily functions, such as blood pressure, heart rate, body ...
Eligibility Criteria
Inclusion
- Adults between the ages of 18 and 60 years of age
- For women of childbearing age, no missed menstrual cycles
- Diagnosis of POTS confirmed by the PI after autonomic function tests
- Able to discontinue GABAergic drugs, beta blockers, and sleep medication for one week before study start-up and for the duration of the study
- Able to read and understand English
Exclusion
- Men and women under 18 and over 60 years of age
- Unable to read or understand English
- A history of gastroparesis, renal or hepatic dysfunction, cardiac arrhythmias, eye disorders and sleep apnea
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04345432
Start Date
January 1 2014
End Date
September 1 2017
Last Update
April 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.